Katja Werlenius
0000-0003-1414-5588
Sahlgrenska universitetssjukhuset
6 papers found
Refreshing results…
A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial
Proton therapy for low-grade gliomas in adults: a systematic review
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells
P06.10 Dose-response relationship of ALECSAT immunotherapy in autologous patient-derived glioblastoma stem cell cultures
Prognostic factors for glioblastoma patients - a clinical population-based study
Missing publications? Search for publications with a matching author name.